No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Blood Année : 2020

No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation

Résumé

The diagnosis of chronic mountain sickness (CMS) is based on a score including 7 clinical features (breathlessness, sleep disturbance, cyanosis, venous dilatation, paresthesia, headache, and tinnitus) in the setting of extreme erythrocytosis. Examining individuals in La Rinconada, Peru, the highest city in the world, the authors demonstrated that CMS at extreme altitude is not linked to elevation of hemoglobin, since CMS+ and CMS− individuals had similar levels of erythrocytosis.

Domaines

Virologie
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée

Dates et versions

inserm-03237676 , version 1 (26-05-2021)

Identifiants

Citer

Pierre Cappy, Daniel Candotti, Virginie Sauvage, Quentin Lucas, Laure Boizeau, et al.. No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation. Blood, 2020, 136 (16), pp.1888-1891. ⟨10.1182/blood.2020008230⟩. ⟨inserm-03237676⟩
75 Consultations
2 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More